Medical Device Labelling Translation for Regulated Markets

Medical device labelling translation is the specialised translation of product labels, outer packaging text, safety statements, symbols descriptions, UDI-related content and regulatory labelling information into the official languages required by the markets where a device is placed. It covers content read by patients, clinicians and supply-chain users, so accuracy, terminology consistency and version alignment with IFUs and technical documentation matter. Under MDR and IVDR, labels accompany the device throughout its lifecycle, which makes labelling translation an ongoing activity rather than a one-off task. AbroadLink delivers this work with qualified medical linguists and ISO-based processes.

No. "Labelling" is the UK English spelling and "labeling" is the US English spelling, and both refer to the same activity: translating product labels, packaging text and regulated labelling content into target languages. Manufacturers selling into EU markets, UK markets and US markets often use both spellings across their documentation, marketing materials and internal procedures. AbroadLink delivers medical device labelling translation and medical device labeling translation under the same processes, using the spelling convention requested by each client. What matters is consistency: once a spelling is chosen for a given product, label or document family, it should be applied uniformly across all translated content.

Medical device manufacturers, IVD manufacturers, regulated product companies, distributors and authorised representatives all need product label translation when placing devices on markets that require local language labelling. Within those organisations, QARA Managers, Regulatory Affairs Managers, Documentation Managers, Product Managers, packaging engineers and localisation teams typically own or coordinate the work. Translation is needed for initial CE marking projects, MDR or IVDR transitions, new country launches, packaging redesigns, supplier or contract manufacturer changes and post-market updates affecting label content. Without compliant multilingual labelling, devices can face market access delays, distribution issues or competent authority observations during inspections and audits.

Under MDR Article 10(11) and IVDR Article 10(10), information accompanying the device must be available in the official languages of each EU Member State where the device is placed or put into service. Specific language obligations are defined nationally, which means requirements vary across countries: some accept English for professional users but demand the national language for lay users, while others always require local languages. Belgium, Finland, Cyprus and Malta have particular national rules. Documents typically affected include labels, IFUs and safety communications. Manufacturers should consult the European Commission MDR and IVDR language requirement tables and monitor national updates regularly.

No. This is one of the most important points in our risk-based approach. The accuracy objective for medical device labelling translation does not change with device class, label length or content type. Lower-risk workflows apply leaner review steps to content where translation risk is lower, while still aiming for accurate, complete and source-faithful translation. Higher-risk workflows add independent revision under ISO 17100 and other controls to reduce the probability and consequences of translation error in safety-critical, lay-user or implantable device labels. The workflow manages how risk is controlled, not whether accurate translation is required.

We assess the labelling project across several dimensions: device class under MDR or IVDR, intended users, safety profile, type of content, target markets, country language requirements and the client's own internal review controls. Based on that profile we propose a workflow. Lower-risk content may be handled with translation plus QA, while higher-risk labels, lay-user content and safety-critical statements typically follow ISO 17100 with independent revision by a second qualified linguist. The manufacturer chooses the workflow that fits its regulatory strategy. AbroadLink supports workflow selection but does not replace the manufacturer's responsibility for risk classification and regulatory compliance.

Both are regulated, but they differ in format, space constraints and reading context. IFU translation deals with longer instructional content, structured sections, diagrams and step-by-step procedures read before or during device use. Labelling translation deals with shorter, denser content placed on the product, packaging or outer cartons, where space is limited, symbols carry meaning, UDI fields appear and safety statements must remain readable at small sizes. Terminology must stay aligned across labels and IFUs, since users encounter both. AbroadLink translates them under the same risk-based logic while applying format-specific handling for each.

No. Translation is one input into a broader compliance system. AbroadLink delivers accurate medical device labelling translation, applies risk-based workflows, uses MDR and IVDR terminology, provides traceable certificates through CertLink and supports your QMS with documented processes. However, the manufacturer remains responsible for risk classification, labelling adequacy, artwork approval, clinical and usability validation, packaging design, notified body interaction, competent authority interaction and final compliance decisions. Multilingual labelling compliance, MDR labelling translation and IVD labelling translation are language-side contributions to compliance, not substitutes for regulatory strategy, clinical evaluation, risk management or product approval activities.